[Federal Register Volume 77, Number 54 (Tuesday, March 20, 2012)]
[Notices]
[Pages 16248-16249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-6719]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Office of AIDS Research Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Office of AIDS Research Advisory Council.
Date: April 10, 2012.
Time: 8:30 a.m. to 5 p.m.
Agenda: The theme of the Office of AIDS Research Advisory
Council (OARAC) meeting will be New Scientific Opportunities in AIDS
Vaccine Research. The speakers at this meeting will focus on
research to address: basic research on HIV vaccine design and
development of new vaccine candidates; new assay systems for
measuring systemic and mucosal immunity to HIV vaccine candidates;
alternative adenovirus vectors; animal models for testing vaccine
candidates; updates on the RV144 clinical trial; and plans for
future clinical trials to advance HIV vaccine candidates to efficacy
testing. An update will be provided on the
[[Page 16249]]
latest changes made to the federal treatment and prevention
guidelines by the OARAC Working Groups responsible for the
guidelines.
Place: National Institutes of Health, 5635 Fishers Lane, Terrace
Level, Suite T-500, Rockville, MD 20852.
Contact Person: Robert Eisinger, Ph.D., Executive Secretary,
Director of Scientific and Program Operations, Therapeutics
Coordinating Committee, Office of AIDS Research, 5635 Fishers Lane,
MSC 9310, Suite 400, Rockville, MD 20852, (301) 496-0357;
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.oar.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: March 14, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-6719 Filed 3-19-12; 8:45 am]
BILLING CODE 4140-01-P